Clinical Laboratory in Texas

Vigilant Biosciences is a biotechnology company specializing in early oral cancer detection through innovative point-of-care diagnostic technologies. Founded in 2011 and based in Lakeway, Texas, the company develops the BeVigilant OraFusion System, a patented non-invasive saliva-based test that detects multiple biomarkers clinically associated with early-stage oral cancer. The system has received FDA Breakthrough Device Designation and IVDR approval for international expansion. With annual revenue of $22 million and approximately 16-22 employees, Vigilant Biosciences primarily serves dental practitioners and healthcare providers seeking to improve oral cancer detection rates and patient outcomes. The company addresses a critical clinical need, as oral cancer—the sixth most common human cancer globally—currently has 5-year survival rates below 50%, with over 70% of cases diagnosed at advanced stages. The BeVigilant OraFusion System enables chairside screening with high accuracy, transforming detection and improving survival outcomes through early intervention.

Trajan Scientific and Medical is a global provider of engineered components, analytical technologies, and medical devices specializing in the sample collection, preparation, measurement, and data generation workflow. Founded in July 2011, the company operates from headquarters in Ringwood, Victoria, Australia, with significant operations across the Americas, Europe, Middle East, Africa, India, and Asia-Pacific regions. The company maintains a strong technical foundation in chromatography and mass spectrometry technologies, enabling laboratory and clinical measurements across biology, food analysis, and environmental testing. Product portfolio encompasses microsample collection devices for clinical trials and pathology, precision components for mass spectrometry systems, automated preparative and sample collection systems, and related consumable materials. Trajan serves research institutions, clinical laboratories, pharmaceutical companies, and diagnostic providers through a global distribution network and direct regional sales offices. The company emphasizes sample integrity, traceability, and measurement quality through engineered physical devices, components, and consumables. Multiple regional service centers provide technical support and instrument sales capabilities.

Traceable® is a manufacturer of precision-certified laboratory instruments and environmental monitoring solutions serving healthcare, pharmaceutical, biotech, food & beverage, and industrial sectors since 1978. The company specializes in NIST-traceable calibration instruments including temperature data loggers, humidity monitors, timers, and digital meters designed for cold chain management, vaccine storage, laboratory testing, and regulated manufacturing environments. All instruments include NIST-Traceable Calibration Certificates and meet CDC and VFC compliance requirements. Traceable® also manufactures TraceableLIVE®, a cloud-based real-time environmental monitoring platform providing live condition readings, instant alerts, and remote access for freezers, laboratories, and distribution centers. The company maintains A2LA-accredited calibration services and serves critical applications requiring audit-ready documentation and strict regulatory compliance across healthcare facilities, research laboratories, pharmaceutical manufacturers, and biotech companies. Manufacturing and calibration services are supported by decades of metrological expertise and global distribution networks.

Gentech Diagnostics is a CLIA/COLA-certified reference laboratory providing comprehensive diagnostic testing services exclusively to healthcare providers. The company specializes in molecular testing and toxicology analysis with rapid turnaround times (24-48 hours for most results). Operating as a B2B laboratory service provider, Gentech Diagnostics does not perform direct-to-patient testing and works exclusively with ordering physicians and healthcare facilities. The laboratory is licensed to serve healthcare providers across Texas, California, and Arizona, with board-certified specialists conducting expert analysis and interpretation of test results. The company is enrolled as a Medicare and Medicaid provider and maintains HIPAA compliance, CAP accreditation, and Privacy Shield certification. Gentech Diagnostics positions itself as a trusted reference laboratory setting standards in medical diagnostics through advanced technology and professional analysis capabilities.

AOSS Medical Supply, Inc. is a US-based distributor and manufacturer of medical supplies and consumables specializing in plasma collection, dialysis, and clinical laboratory products. The company operates an FDA-certified kit packing facility and offers customized nursing and medical school kits. Primary product lines include blood collection tubes (BD Vacutainer, BD Microtainer), fistula needles for arteriovenous fistulas (JMS products), dialysis supplies and accessories, plasma collection solutions, laboratory consumables, personal protective equipment (PPE), and wound care products. AOSS serves diverse markets including dialysis centers, plasma collection facilities, clinical laboratories, EMS providers, dental practices, tattoo studios, educational institutions, food and beverage, spa, and janitorial sectors. The company emphasizes bulk order discounts, fast and secure shipping (2–3 day processing, 5–7 day delivery domestically), customer service support, and satisfaction guarantees. Leadership includes CEO Eric Liew and COO/President Linda Liew. AOSS maintains quality focus and offers products meeting FDA approval standards. The company handles physician license verification for restricted products and provides 30-day returns (excluding PPE items). No specific regulatory certifications (510(k), ISO 13485, CE marking) are explicitly stated on the site, though FDA-certified kit packing capability is mentioned.

Healgen Scientific LLC is a global in-vitro diagnostics (IVD) developer and manufacturer established in 2007 in Houston, Texas. The company specializes in rapid point-of-care (POC) diagnostic testing technologies across multiple therapeutic areas: infectious diseases (COVID-19, influenza, Strep A), toxicology (drug screening, fentanyl/xylazine residue detection), fertility and women's health, oncology, cardiovascular, and metabolic disorders. Healgen's product portfolio includes rapid test cassettes, cups, and oral fluid devices—many FDA 510(k) cleared and CLIA-waived. Notable products include the Accurate® Multi-Drug Urine Drug Screen Cup (18-in-1 detection), Rapid Check® COVID-19/Flu A&B Antigen Test (available for both professional and OTC use), Fentanyl Rapid Tests, Strep A tests, and recently FDA De Novo-cleared Accurate® Oral Fluid Device. The company markets solutions to healthcare providers, workplace testing programs, public health organizations, and consumers. Healgen maintains global service centers and business partnerships across multiple countries and regions. Manufacturing and quality systems support FDA and international regulatory compliance.

Gene by Gene is a Houston-based CLIA-certified, CAP-accredited, and COLA-accredited clinical laboratory specializing in advanced genetic testing services. Founded in 2000, the company operates as a subsidiary of myDNA Inc. and provides a comprehensive spectrum of laboratory services including whole genome sequencing (WGS), whole exome sequencing (WES), custom targeted NGS panels, SNP array analysis, Sanger sequencing, and pharmacogenomics testing. The company serves clinical practitioners, researchers, and healthcare organizations globally with rapid turnaround times and competitive pricing. Gene by Gene's in-house laboratory features robotic automation and scalable sequencing and microarray technologies. Services extend to forensic genetics (through partnership with Verogen Inc.), paternity and relationship testing, population genetics research, and biobanking. The laboratory holds permits from multiple states including California, New York, Pennsylvania, and Maryland, and is AABB-accredited for relationship testing, ensuring exceptional result accuracy and compliance with regulatory standards.

SA Scientific, Ltd. is a USA-based manufacturer of rapid diagnostic kits founded in 1984. The company designs, develops, and manufactures a broad portfolio of one-step rapid tests for human diagnostics including fertility and infectious disease detection, veterinary diagnostics, biowarfare testing, and food safety pathogen detection. SA Scientific employs multiple proprietary testing technologies: colloidal gold lateral flow assays, fluorescent-based lateral flow systems, and rapid molecular test platforms. With over 35 OEM diagnostic products, the company serves clinical laboratories, healthcare practitioners, and research institutions globally. All manufacturing is performed in-house in the USA. The company holds FDA and USDA approvals, ISO 9001-2008 and ISO 13485 certifications, and CE Mark designation, demonstrating compliance with stringent quality and regulatory standards across North American, European, and international markets.

Asuragen is a molecular diagnostics company specializing in genetic carrier screening and precision oncology testing. Founded in 2006 and acquired by Bio-Techne Corporation in 2021, the company develops advanced diagnostic solutions utilizing proprietary chemistries and miRNA-based technologies. Their product portfolio includes genetic testing kits for inherited disorders (Fragile X, CFTR, SMN1/2, HTT), precision oncology solutions for chronic myeloid leukemia (CML) and solid tumor monitoring, custom molecular quality controls, and armored RNA controls. The AmplideX product line encompasses PCR/CE-based assays optimized for clinical laboratories. Asuragen operates a GMP-compliant manufacturing facility and CLIA-certified laboratory, serving clinical diagnostics and research applications across oncology, genetic disorders, and carrier screening markets. The company maintains strategic partnerships and distributes products across North America and EMEA regions.

C.G. Laboratories, Inc. is a multi-service medical device contract manufacturer and testing laboratory founded in 1983 and headquartered in Granbury, Texas. The company specializes in medical device decontamination, contract packaging, laboratory testing, sterilization validation, and environmental monitoring. With over 40 years of operational experience and 19,000 square feet across two facilities, C.G. Labs serves the medical device, tissue, and dental industries. The company is FDA-registered and ISO 13485:2016 and MDSAP accredited. Core competencies include microbiological analysis, regulatory testing, reusable medical device validation, water testing, air microbial monitoring, and IFU development. C.G. Labs offers customizable decontamination and sterilization services with turnaround times exceeding 72-hour performance objectives, end-to-end contract packaging (sterile and non-sterile), and comprehensive validation support including process validation and equipment qualification. The laboratory team collectively has over 90 years of medical device industry experience.

mLife Diagnostics LLC is a medical diagnostics company specializing in oral fluid collection and rapid drug screening devices. The company manufactures two primary product lines: mLife True, an oral fluid collection device utilizing oral swabs with glass vials accommodating neat samples or samples with buffer/preservative up to 3ml; and mLife Verify, a rapid screening tool for drugs of abuse featuring an industry-patented design that accommodates up to 14 assay strips for immediate results while simultaneously collecting a split sample in glass for laboratory confirmation via LC-MS/MS analysis. mLife's oral fluid testing platform claims 99.9% accuracy and is marketed for workplace drug testing and law enforcement applications. The technology eliminates need for gender-specific specimen collectors and observed collections in private areas, reducing administrative burden and sample handling time. Products enable both point-of-care screening and chain-of-custody compliant laboratory confirmation. The company positions oral fluid testing as advantageous over urine and blood methods due to non-invasive collection, resistance to adulteration, and rapid detection window (immediately after ingestion through approximately four days). Regulatory status and specific FDA/ISO certifications are not detailed on the fetched content.